Search research articles
Contact Us
Filters
Showing results (181-190 of 251) with videos related to
Page
of 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2026
Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)
Chibawanye I Ene, Sanjay Singh, Thiagarajan Venkataraman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group
Sandeep Kunwar, Michael D Prados, Susan M Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas
Alessandro Canella, Alessandra M Welker, Ji Young Yoo, et al.
Neuro-Oncology Advances
|
March 13, 2026
Perioperative neurocognitive functioning in elderly patients undergoing awake craniotomy for high grade glioma
Eric A Goethe, Kyle R Noll, Subhiksha Srinivasan, et al.
Cancer Research
|
May 3, 2013
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma
Jun Wei, Fei Wang, Ling-Yuan Kong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2003
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results
Frederick F Lang, Janet M Bruner, Gregory N Fuller, et al.
Neuro-Oncology
|
April 7, 2019
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis
Anantha L Marisetty, Li Lu, Bethany L Veo, et al.
Neuro-Oncology Advances
|
January 7, 2026
Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma
Lea M Stitzlein, Deokhwa Nam, Faith A Hernandez, et al.
Acta Neuropathologica Communications
|
January 19, 2024
The genomic alterations in glioblastoma influence the levels of CSF metabolites
Daniel H Wang, Yoko Fujita, Antonio Dono, et al.
Journal of Cellular Physiology
|
May 22, 2024
Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus
Praveen Bhoopathi, Padmanabhan Mannangatti, Anjan K Pradhan, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 251) with videos related to
Sort By:
Page
of 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2026
Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)
Chibawanye I Ene, Sanjay Singh, Thiagarajan Venkataraman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2007
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group
Sandeep Kunwar, Michael D Prados, Susan M Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas
Alessandro Canella, Alessandra M Welker, Ji Young Yoo, et al.
Neuro-Oncology Advances
|
March 13, 2026
Perioperative neurocognitive functioning in elderly patients undergoing awake craniotomy for high grade glioma
Eric A Goethe, Kyle R Noll, Subhiksha Srinivasan, et al.
Cancer Research
|
May 3, 2013
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma
Jun Wei, Fei Wang, Ling-Yuan Kong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2003
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results
Frederick F Lang, Janet M Bruner, Gregory N Fuller, et al.
Neuro-Oncology
|
April 7, 2019
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis
Anantha L Marisetty, Li Lu, Bethany L Veo, et al.
Neuro-Oncology Advances
|
January 7, 2026
Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma
Lea M Stitzlein, Deokhwa Nam, Faith A Hernandez, et al.
Acta Neuropathologica Communications
|
January 19, 2024
The genomic alterations in glioblastoma influence the levels of CSF metabolites
Daniel H Wang, Yoko Fujita, Antonio Dono, et al.
Journal of Cellular Physiology
|
May 22, 2024
Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus
Praveen Bhoopathi, Padmanabhan Mannangatti, Anjan K Pradhan, et al.
Page
of 26